Safety of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

figure

posted on 2020-08-07, 16:32 authored by Joseph A. Lasky, Gerard J. Criner, Howard M. Lazarus, Veronika Kohlbrenner, Shaun Bender, Luca Richeldi

Article full text

The above summary slide and graphical plain language summary represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).